Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:FSICNYSE:MAANYSE:RFNASDAQ:RPRX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFSICFS Investment$21.16-1.1%$6.13$5.32▼$8.24$5.06B0.951.39 million shs1.11 million shsMAAMid-America Apartment Communities$150.09-0.3%$154.57$137.51▼$173.38$17.61B0.75798,073 shs1.26 million shsRFRegions Financial$24.57-0.9%$22.08$17.74▼$27.96$22.29B0.988.33 million shs7.65 million shsRPRXRoyalty Pharma$35.59-2.1%$33.94$24.05▼$36.43$20.45B0.53.66 million shs3.33 million shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFSICFS Investment0.00%+3.63%+0.42%+16.00%+6.10%MAAMid-America Apartment Communities-0.25%+1.43%+0.10%+0.02%+8.13%RFRegions Financial-0.45%+4.38%+11.28%+34.89%+25.94%RPRXRoyalty Pharma-2.02%-1.22%+5.36%+15.36%+38.64%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFSICFS InvestmentN/AN/AN/AN/AN/AN/AN/AN/AMAAMid-America Apartment Communities4.7774 of 5 stars3.24.04.22.93.02.50.6RFRegions Financial4.8788 of 5 stars2.34.05.03.43.31.72.5RPRXRoyalty Pharma4.8873 of 5 stars3.61.03.33.73.61.72.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFSICFS Investment 0.00N/AN/AN/AMAAMid-America Apartment Communities 2.43Hold$169.7613.11% UpsideRFRegions Financial 2.52Moderate Buy$26.156.43% UpsideRPRXRoyalty Pharma 3.25Buy$47.3333.00% UpsideCurrent Analyst Ratings BreakdownLatest FSIC, RPRX, MAA, and RF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/3/2025RFRegions FinancialMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$22.00 ➝ $27.007/2/2025RFRegions FinancialCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$26.00 ➝ $27.006/24/2025MAAMid-America Apartment CommunitiesRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform6/13/2025MAAMid-America Apartment CommunitiesScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Outperform ➝ Sector Outperform$194.00 ➝ $180.006/3/2025RFRegions FinancialStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$24.005/23/2025RFRegions FinancialTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold5/23/2025MAAMid-America Apartment CommunitiesMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$166.00 ➝ $161.005/22/2025MAAMid-America Apartment CommunitiesJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Outperform ➝ Market Outperform$160.00 ➝ $170.005/21/2025MAAMid-America Apartment CommunitiesTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$174.00 ➝ $171.005/21/2025RFRegions FinancialJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Hold$24.005/16/2025RPRXRoyalty PharmaMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$51.00(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFSICFS Investment$419.31M12.07$3.36 per share6.30$9.30 per share2.28MAAMid-America Apartment Communities$2.19B8.02$9.56 per share15.70$52.41 per share2.86RFRegions Financial$7.12B3.10$2.41 per share10.19$17.82 per share1.38RPRXRoyalty Pharma$2.26B8.84$4.10 per share8.67$17.56 per share2.03Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFSICFS Investment$181.98M$0.8325.4926.452.21-3.73%9.57%5.31%N/AMAAMid-America Apartment Communities$527.54M$4.8031.2716.283.8525.70%9.19%4.81%7/30/2025 (Estimated)RFRegions Financial$1.89B$2.0811.819.911.9721.43%13.04%1.36%7/18/2025 (Estimated)RPRXRoyalty Pharma$858.98M$1.8519.247.321.8748.23%24.71%13.87%8/6/2025 (Estimated)Latest FSIC, RPRX, MAA, and RF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025MAAMid-America Apartment Communities$2.16N/AN/AN/A$552.19 millionN/A7/18/2025Q2 2025RFRegions Financial$0.56N/AN/AN/A$1.86 billionN/A5/8/2025Q1 2025RPRXRoyalty Pharma$0.99$1.06+$0.07$0.41$724.69 million$839.00 million4/30/2025Q1 2025MAAMid-America Apartment Communities$2.16$2.20+$0.04$2.20$551.21 million$549.30 million4/17/2025Q1 2025RFRegions Financial$0.51$0.54+$0.03$0.51$1.84 billion$1.81 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFSICFS Investment$0.763.59%N/A91.57%N/AMAAMid-America Apartment Communities$6.064.04%N/A126.25%16 YearsRFRegions Financial$1.004.07%N/A48.08%12 YearsRPRXRoyalty Pharma$0.882.47%N/A47.57%5 YearsLatest FSIC, RPRX, MAA, and RF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/20/2025MAAMid-America Apartment Communitiesquarterly$1.51503.78%7/15/20257/15/20257/31/20254/16/2025RFRegions Financialquarterly$0.255.21%6/2/20255/2/20257/1/20254/21/2025RPRXRoyalty Pharmaquarterly$0.222.7%5/16/20255/16/20256/10/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFSICFS Investment0.751.941.94MAAMid-America Apartment Communities0.820.110.11RFRegions Financial0.360.840.83RPRXRoyalty Pharma0.681.561.56Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFSICFS Investment29.47%MAAMid-America Apartment Communities93.60%RFRegions Financial79.39%RPRXRoyalty Pharma54.35%Insider OwnershipCompanyInsider OwnershipFSICFS Investment1.07%MAAMid-America Apartment Communities1.30%RFRegions Financial0.29%RPRXRoyalty Pharma18.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFSICFS InvestmentN/A239.15 millionN/ANot OptionableMAAMid-America Apartment Communities2,532117.06 million115.54 millionOptionableRFRegions Financial19,644898.93 million896.32 millionOptionableRPRXRoyalty Pharma80562.24 million455.98 millionOptionableFSIC, RPRX, MAA, and RF HeadlinesRecent News About These CompaniesRoyalty Pharma PLC (NASDAQ:RPRX) Shares Bought by Sumitomo Mitsui DS Asset Management Company LtdJuly 6 at 4:12 AM | marketbeat.comRoyalty Pharma PLC (NASDAQ:RPRX) Shares Bought by KBC Group NVJuly 4, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Sells 88,416 Shares of Royalty Pharma PLC (NASDAQ:RPRX)July 3, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Purchases 21,729 Shares of Royalty Pharma PLC (NASDAQ:RPRX)July 3, 2025 | marketbeat.comRoyalty Pharma PLC (NASDAQ:RPRX) Shares Purchased by Mirae Asset Global Investments Co. Ltd.July 3, 2025 | marketbeat.comRoyalty Pharma PLC (NASDAQ:RPRX) Stake Reduced by New South Capital Management Inc.July 2, 2025 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Sets New 52-Week High - Here's WhyJuly 1, 2025 | marketbeat.comRoyalty Pharma: Attractive Acquisition With Upside Risk/Reward On Current PipelineJuly 1, 2025 | seekingalpha.comInvestors in Royalty Pharma (NASDAQ:RPRX) have seen respectable returns of 40% over the past yearJune 29, 2025 | finance.yahoo.comRoyalty Pharma PLC (NASDAQ:RPRX) Holdings Raised by Robeco Institutional Asset Management B.V.June 29, 2025 | marketbeat.comAsset Management One Co. Ltd. Acquires 12,148 Shares of Royalty Pharma PLC (NASDAQ:RPRX)June 29, 2025 | marketbeat.comWall Street Zen Downgrades Royalty Pharma (NASDAQ:RPRX) to HoldJune 29, 2025 | marketbeat.comRPRX Royalty Pharma plc - Seeking AlphaJune 28, 2025 | seekingalpha.comRoyalty Pharma plc (RPRX) Balance Sheet - Yahoo FinanceJune 28, 2025 | finance.yahoo.comRoyalty Pharma PLC (NASDAQ:RPRX) Holdings Decreased by Overbrook Management CorpJune 28, 2025 | marketbeat.comRoyalty Pharma plc - Ordinary Shares - Class A RPRX OverviewJune 28, 2025 | money.usnews.comMarathon Asset Management Ltd Sells 68,924 Shares of Royalty Pharma PLC (NASDAQ:RPRX)June 28, 2025 | marketbeat.comRoyalty Pharma PLC (NASDAQ:RPRX) Shares Sold by Paragon Capital Management Inc.June 27, 2025 | marketbeat.com31,200 Shares in Royalty Pharma PLC (NASDAQ:RPRX) Acquired by Board of the Pension Protection FundJune 27, 2025 | marketbeat.com2 Surging Stocks to Research Further and 1 to Be Wary OfJune 26, 2025 | finance.yahoo.comPhillips Wealth Planners LLC Takes Position in Royalty Pharma PLC (NASDAQ:RPRX)June 26, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeFSIC, RPRX, MAA, and RF Company DescriptionsFS Investment NYSE:FSICFS KKR Capital Corp. is an externally managed, non-diversified, closed-end management investment and finance company that invests primarily in the debt securities of private middle market U.S. companies. Its objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company was founded by Michael Craig Forman on December 21, 2007 and is headquartered in Philadelphia, PA.Mid-America Apartment Communities NYSE:MAA$150.09 -0.38 (-0.25%) Closing price 07/7/2025 03:59 PM EasternExtended Trading$150.07 -0.02 (-0.01%) As of 07/7/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mid-America Apartment Communities, Inc. is a real estate investment trust, which engages in the operation, acquisition, and development of apartment communities. It operates through the Same Store and Non-Same Store segments. The Same Store Communities segment represents those apartment communities that have been owned and stabilized for at least 12 months as of the first day of the calendar year. The Non-Same Store segment includes recent acquisitions, communities in development or lease-up. The company was founded in 1994 and is headquartered in Germantown, TN.Regions Financial NYSE:RF$24.57 -0.23 (-0.93%) Closing price 07/7/2025 03:59 PM EasternExtended Trading$24.48 -0.09 (-0.39%) As of 07/7/2025 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Regions Financial Corporation, a financial holding company, provides banking and bank-related services to individual and corporate customers. It operates through three segments: Corporate Bank, Consumer Bank, and Wealth Management. The Corporate Bank segment offers commercial banking services, such as commercial and industrial, commercial real estate, and investor real estate lending; equipment lease financing; deposit products; and securities underwriting and placement, loan syndication and placement, foreign exchange, derivatives, merger and acquisition, and other advisory services. It serves corporate, middle market, and commercial real estate developers and investors. The Consumer Bank segment provides consumer banking products and services related to residential first mortgages, home equity lines and loans, consumer credit cards, and other consumer loans, as well as deposits. The Wealth Management segment offers credit related products, and retirement and savings solutions; and trust and investment management, asset management, and estate planning services to individuals, businesses, governmental institutions, and non-profit entities. It also provides investment and insurance products; low-income housing tax credit corporate fund syndication services; and other specialty financing services. The company was founded in 1971 and is headquartered in Birmingham, Alabama.Royalty Pharma NASDAQ:RPRX$35.59 -0.78 (-2.14%) Closing price 07/7/2025 04:00 PM EasternExtended Trading$35.67 +0.08 (+0.24%) As of 07/7/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
